ISSYS raises funds for drug delivery products

Sep. 16, 2005 — Integrated Sensing Systems Inc. (ISSYS) in Ypsilanti, Mich., announced that it has been awarded $950,000 over a two-year period from the Michigan Technology Tri-Corridor Fund.

The award is dedicated to commercializing drug infusion products developed at ISSYS. Douglas Sparks, executive vice president, said in a prepared statement that the system ISSYS is developing can greatly reduce the number of errors seen during drug delivery by monitoring the drug dose, dose rate, volume, drug type and concentration. He said it can also detect occlusions or blockages in an IV line and sense air bubbles.

ISSYS, founded in 1995, develops advanced micromachining technologies for medical devices, microfluidic and scientific analytical sensing applications used in the development of drug infusion pumps and wireless, implantable sensing systems.


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.